Impact of intermittent preventive treatment with sulfadoxine-pyrimethamine on antibody responses to erythrocytic-stage Plasmodium falciparum antigens in infants in Mozambique
Clin. vaccine immunol; 15 (8), 2008
We evaluated the impact of intermittent preventive treatment in infants (IPTi) with sulfadoxine-pyrimethamine (SP), which was given at ages 3, 4, and 9 months through the Expanded Program on Immunization (EPI), on the development of antibody responses to Plasmodium falciparum in Mozambique. Immunoglobuli...
Antibodies, Protozoan/blood, Antibodies, Protozoan/immunology, Antibodies, Protozoan/genetics, Antimalarials/administration & dosage, Antimalarials/therapeutic use, Malaria, Falciparum/immunology, Malaria, Falciparum/prevention & control, Plasmodium falciparum/immunology, Pyrimethamine/administration & dosage, Mozambique, Recombinant Proteins/genetics, Recombinant Proteins/immunology